WHO releases new target product profiles for urgently needed antibiotics: Geneva Thursday, March 12, 2026, 09:00 Hrs [IST] The World Health Organization (WHO) published three new ...

A communication pathway between the brain and the gut may be integral to how well the brain holds on to memories.

Scientists have created a genomic blueprint for Aeromonas bacteria, which can cause antibiotic-resistant diarrheal disease—with symptoms often misidentified as cholera—in humans and animals.

Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...

A study of about 15,000 adults finds a lasting association between the use of certain antibiotics and the balance of the intestinal microbiota. The intestinal microbiota, that community of bacteria ...

We need a reliable pipeline with new antibacterial agents that are innovative, affordable, accessible to all those who need ...

A bacterium already famous for shrugging off extreme radiation and desiccation has now passed another brutal test: surviving ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections Qualified Infectious Disease ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...

When cows develop mastitis, dairies often respond with immediate antibiotic treatment. That approach has long protected animal health and milk production. But research suggests treating every case ...

There are four classes of anti-infectives used for BRD treatment. It is impotant to use the correct class of antibiotic to ...

GARDP has acquired all data and licensing rights for apramycin, an aminoglycoside antibiotic used in veterinary medicine, and will evaluate its potential to treat highly drug-resistant infections in ...